Clinical significance of cadherin-6 expression in primary and recurrent epithelial ovarian cancer and its association with outcomes: A potential therapeutic target for epithelial ovarian cancer

被引：0
|
作者：
Shintani, Daisuke [1 ]
Hanaoka, Mieko [1 ]
Sato, Sho [1 ]
Yano, Mitutake [2 ]
Ogasawara, Aiko [1 ]
Kato, Tomomi [1 ]
Yabuno, Akira [1 ]
Yasuda, Masanori [2 ]
Kaneda, Yuki [3 ]
Nagata, Motoko [3 ]
Hasegawa, Kosei [1 ]
机构：
[1] Saitama Med Univ Int Med Ctr, Hidaka, Japan
[2] Daiichi Sankyo Co Ltd, Tokyo, Japan
[3] Daiichi Sankyo Co Ltd, Tokyo, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
206
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [41] The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer
    Gui, Ting
    Shen, Keng
    [J]. CANCER EPIDEMIOLOGY, 2012, 36 (05) : 490 - 496
  • [42] CHTOP is a novel therapeutic target for chemoresistant epithelial ovarian cancer therapy
    Bai, Xupeng
    Feng, Xiaojie
    Ni, Jie
    Beretov, Julia
    Deng, Junli
    Zhu, Ying
    Graham, Peter
    Li, Yong
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [43] mTORC2 is a promising therapeutic target in epithelial ovarian cancer
    Hisamatsu, Takeshi
    Mabuchi, Seiji
    Hashimoto, Kae
    Isobe, Aki
    Sawada, Kenjiro
    Kimura, Tadashi
    [J]. CANCER RESEARCH, 2012, 72
  • [44] BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer
    Clark-Knowles, Katherine V.
    O'Brien, Anna M.
    Weberpals, Johanne I.
    [J]. JOURNAL OF ONCOLOGY, 2010, 2010
  • [45] Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer
    Kusumoto, Tomoyuki
    Kodama, Junichi
    Seki, Noriko
    Nakamura, Keiichiro
    Hongo, Atsushi
    Hiramatsu, Yuji
    [J]. ONCOLOGY REPORTS, 2010, 23 (04) : 917 - 925
  • [46] Increased expression of LncRNA BANCR and its prognostic significance in human epithelial ovarian cancer
    Xu, X.
    Pan, L.
    Zhuo, M.
    Yang, X.
    Zhang, W.
    Sun, D.
    Zeng, N.
    Zhang, D.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (03) : 449 - 452
  • [47] Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance
    Ayhan, A
    Ertunc, D
    Tok, EC
    Ayhan, A
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (04) : 618 - 623
  • [48] Outcomes of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Gockley, A. A.
    Cronin, A.
    Bookman, M. A.
    Burger, R. A.
    Cristea, M.
    Griggs, J. J.
    Mantia-Smaldone, G. M.
    Meyer, L. A.
    O'Malley, D. M.
    Wright, A. A.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 81 - 82
  • [49] Treatment Outcomes of Gemcitabine in Refractory or Recurrent Epithelial Ovarian Cancer Patients
    Chanpanitkitchot, Saranya
    Tangjitgamol, Siriwan
    Khunnarong, Jakkapan
    Thavaramara, Thaowalai
    Pataradool, Kamol
    Srijaipracharoen, Sunamchok
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (13) : 5215 - 5221
  • [50] Profiling the immune tumor microenvironment in primary and recurrent epithelial ovarian cancer
    Ojalvo, Laureen S.
    Thompson, Elizabeth D.
    Wang, Tian-Li
    Meeker, Alan K.
    Shih, Ie-Ming
    Fader, Amanda N.
    Cimino-Mathews, Ashley
    Emens, Leisha A.
    [J]. CANCER RESEARCH, 2017, 77
12345